
Sculpt Rx
Telehealth weight management for California and Florida adults, with licensed providers prescribing compounded semaglutide, tirzepatide and other GLP-1 medications.
About Sculpt Rx
Telehealth weight management for California and Florida
Sculpt Rx is a cash-pay telehealth service offering medical weight management for adults aged 18 and older who live in California or Florida. Care is delivered entirely remotely: a nurse practitioner reviews the patient's health history, determines whether GLP-1 treatment is appropriate, and, when a prescription is issued, the medication ships from a licensed pharmacy to the patient's home.
The service is operated by KDRN Holdings Inc., doing business as Sculpt Rx. A registered nurse, identified as Kay, RN, appears as co-founder and clinical specialist.
Medications and treatment
The programme covers evaluation, clinical oversight and ongoing support for patients prescribed:
- Compounded semaglutide
- Compounded tirzepatide
- Zepbound
- Foundayo (orforglipron)
Compounded drugs are not FDA-approved. Prescribing is never guaranteed: decisions rest with the licensed provider after a medical evaluation. Medications are dispensed by state-licensed U.S. pharmacies regulated by state boards of pharmacy. The company also lists vitamin therapy among its offerings.
How the process works
- A complimentary consultation to answer questions and explain the process.
- Screening by a nurse practitioner who reviews health history and eligibility.
- Delivery of the medication to the patient's home if prescribed, with instructions and access to a personal registered nurse.
- Continued nurse support during treatment, including dose adjustments and check-ins.
Clinical support model
Each patient is assigned a dedicated nurse with what the company describes as unlimited access throughout treatment. Dosing is individualised and adjusted according to the patient's response rather than a fixed template. Support covers side-effect management, guidance during plateaus and regular check-ins. The company frames this hands-on follow-up as its response to a common gap in GLP-1 care, where patients report unclear guidance, difficulty reaching a provider and unmanaged side effects.
According to figures cited by the company, about 50% of people stop GLP-1 medications within a year and 30% quit in the first month alone.
Payment and coverage limits
Sculpt Rx does not accept insurance and operates on a cash-pay basis, with payment terms disclosed before enrolment. FSA and HSA payments are accepted. The service is non-emergency only and does not provide emergency care; patients with a medical emergency are directed to call 911.
GLP-1 medical weight loss via telehealth